Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Name: Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
License: Public Domain

The First Affiliated Hospital of Nanchang University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 394744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.